For one, it suggests that the metabolic benefits driven by the glucagon pathway (like increased thermogenesis) might be intrinsically linked to these cardiovascular changes
it occurs with almost any significant weight loss
For example, participants in the trials reported side effects that were generally consistent with previous studies, such as gastrointestinal symptoms, which are one of the main reasons that can lead to discontinuation of the drugs
Kumar, microdosing involves clinically guided doses that are lower than the standard amount for weight loss
The trouble is you cannot be assured of that because you don't really know what's going on behind the door at the pharmacy
The SELECT trial, which supports the expanded indication, enrolled patients 45 years of age and older with pre-existing cardiovascular disease and a body-mass index of 27 or greater without diabetes